Metformin Bluefish (Metformin Hydrochloride)

Metformin reduces hepatic glucose production, decreases intestinal glucose absorption, and increases peripheral insulin sensitivity. These actions are mediated mainly through activation of AMP‑activated protein kinase (AMPK), which shifts cellular metabolism toward glucose utilization and away from gluconeogenesis.

The dosage of Metformin Bluefish is individualized by the prescribing clinician based on the patient’s glycaemic targets, renal function, and tolerability. Typical regimens start with a low dose that is gradually increased, but the exact strength and schedule must be defined by the healthcare provider.

Data on Metformin use during pregnancy are limited, and it is generally prescribed only when the potential benefit outweighs potential risks. Metformin is excreted in breast milk, so breastfeeding mothers should discuss alternatives with their physician before continuing therapy.

To place an order, submit an enquiry on the Metformin Bluefish product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Metformin is the first‑line oral therapy for type 2 diabetes because it lowers glucose without causing weight gain or significant hypoglycaemia, unlike sulfonylureas or insulin. Compared with newer agents such as SGLT‑2 inhibitors or GLP‑1 receptor agonists, Metformin is less expensive and has a well‑established safety profile, though it may be combined with those agents for additional benefit.

Metformin Bluefish should be stored at room temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Metformin Bluefish is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a glass of water; they are not intended for crushing, chewing, or dissolving unless specifically instructed by a healthcare professional.

The most serious adverse reaction is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or excessive alcohol intake. Other serious concerns include severe allergic reactions and hepatotoxicity, which require immediate medical attention if symptoms arise.

Metformin is contraindicated in patients with known hypersensitivity to metformin or other biguanides, severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and those receiving iodinated contrast studies without adequate renal monitoring. Caution is also advised in individuals with unstable heart failure.